These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 10068210)
1. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Martin DC; Sanchez-Sweatman OH; Ho AT; Inderdeo DS; Tsao MS; Khokha R Lab Invest; 1999 Feb; 79(2):225-34. PubMed ID: 10068210 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Martin DC; Rüther U; Sanchez-Sweatman OH; Orr FW; Khokha R Oncogene; 1996 Aug; 13(3):569-76. PubMed ID: 8760297 [TBL] [Abstract][Full Text] [Related]
3. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Terada T; Okada Y; Nakanuma Y Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149 [TBL] [Abstract][Full Text] [Related]
4. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis. Bloomston M; Shafii A; Zervos EE; Rosemurgy AS J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150 [TBL] [Abstract][Full Text] [Related]
5. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer. Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163 [TBL] [Abstract][Full Text] [Related]
6. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice. Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086 [TBL] [Abstract][Full Text] [Related]
7. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury. Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161 [TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Yoshiji H; Kuriyama S; Miyamoto Y; Thorgeirsson UP; Gomez DE; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Thorgeirsson SS; Fukui H Hepatology; 2000 Dec; 32(6):1248-54. PubMed ID: 11093731 [TBL] [Abstract][Full Text] [Related]
11. Altered tumor angiogenesis and metastasis of B16 melanoma in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1. de Lorenzo MS; Ripoll GV; Yoshiji H; Yamazaki M; Thorgeirsson UP; Alonso DF; Gomez DE In Vivo; 2003; 17(1):45-50. PubMed ID: 12655789 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Matsunaga Y; Koda M; Murawaki Y Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523 [TBL] [Abstract][Full Text] [Related]
14. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Hirata M; Sato T; Tsumagari M; Shimada A; Nakano H; Hashizume K; Ito A Biol Reprod; 2003 Apr; 68(4):1276-81. PubMed ID: 12606436 [TBL] [Abstract][Full Text] [Related]
16. TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis. Cruz-Muñoz W; Kim I; Khokha R Oncogene; 2006 Jan; 25(4):650-5. PubMed ID: 16186800 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis. Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257 [TBL] [Abstract][Full Text] [Related]
18. Increased TIMP-1 activity results in increased expression of gelatinases and altered cell motility. Roeb E; Winograd R; Breuer B; Nguyen H; Matern S J Cell Biochem; 1999 Nov; 75(2):346-55. PubMed ID: 10502306 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
20. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats. Hu YB; Li DG; Lu HM J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]